Risk Management Only Part Of Behind-The-Counter Orders – Von Eschenbach

Enactment of legislation to strengthen FDA's post-marketing authority is not the only hurdle to clear before the agency could begin requiring behind-the-counter sales of certain nonprescription drugs, Commissioner Andrew von Eschenbach says